Historique
Article de Périodique
Prevalence and factors associated with tobacco and cannabis co-use in France: Results from a national representative survey (2025)
Auteur(s) :
BARRÉ, T. ;
DI BEO, V. ;
PROTOPOPESCU, C. ;
LAHAIE, E. ;
ANDLER, R. ;
NGUYEN THANH, V. ;
PASQUEREAU, A. ;
CARRIERI, P. ;
BECK, F.
Année
2025
Page(s) :
art. 100381
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs ; Tabac / Tobacco / e-cigarette
Discipline :
EPI (Epidémiologie / Epidemiology)
Thésaurus géographique
FRANCE
Thésaurus mots-clés
BAROMETRE SANTE
;
TABAC
;
CANNABIS
;
POLYCONSOMMATION
;
PREVALENCE
;
ADULTE
;
ETUDE TRANSVERSALE
;
CATEGORIE SOCIO-PROFESSIONNELLE
Organismes
SANTE PUBLIQUE FRANCE
Résumé :
Background and aims: Tobacco use is a leading global risk factor for premature mortality. Cannabis-related harms are well documented, and its co-use with tobacco may hinder smoking cessation efforts. Moreover, tobacco use may amplify certain cannabis-related harms. To inform targeted interventions, we provided estimates of tobacco and cannabis co-use prevalence and correlates in France.
Methods: Using data from a 2021 nationwide representative sample of French population aged 18-64 years, we estimated the prevalence of tobacco and cannabis co-use. Co-use was defined as reporting daily cigarette smoking and at least monthly cannabis use. We used multinomial logistic regression models to identify factors associated with co-use.
Results: Among the 18,288 study participants, 71.8% reported no use of cannabis or tobacco ('no-use' group), 22.3% tobacco mono-use, 1.4% cannabis mono-use, and 4.5% co-use of both substances. Individuals who co-used reported a more frequent cannabis use than those who mono-used cannabis. Having financial difficulties was significantly associated with co-use, compared to tobacco and cannabis mono-use. After multivariable adjustment, the odds of co-use compared with 'no-use' was 2.3 times higher for participants with a poor health status, and 3.0 times higher for those with financial difficulties. Reporting a major depressive episode and unhealthy alcohol use were also significantly associated with co-use.
Conclusions: The clinical management of individuals who co-use tobacco and cannabis should include comprehensive assessments of physical and mental health, as well as alcohol consumption. Interventions to reduce co-use-related harms should also address the adverse social conditions experienced by this population. [Author's abstract]
Highlights:
Five percent of French adults co-use tobacco and cannabis.
Most French adults who use cannabis use also tobacco.
Tobacco and cannabis co-use is associated with a lower socioeconomic status.
Methods: Using data from a 2021 nationwide representative sample of French population aged 18-64 years, we estimated the prevalence of tobacco and cannabis co-use. Co-use was defined as reporting daily cigarette smoking and at least monthly cannabis use. We used multinomial logistic regression models to identify factors associated with co-use.
Results: Among the 18,288 study participants, 71.8% reported no use of cannabis or tobacco ('no-use' group), 22.3% tobacco mono-use, 1.4% cannabis mono-use, and 4.5% co-use of both substances. Individuals who co-used reported a more frequent cannabis use than those who mono-used cannabis. Having financial difficulties was significantly associated with co-use, compared to tobacco and cannabis mono-use. After multivariable adjustment, the odds of co-use compared with 'no-use' was 2.3 times higher for participants with a poor health status, and 3.0 times higher for those with financial difficulties. Reporting a major depressive episode and unhealthy alcohol use were also significantly associated with co-use.
Conclusions: The clinical management of individuals who co-use tobacco and cannabis should include comprehensive assessments of physical and mental health, as well as alcohol consumption. Interventions to reduce co-use-related harms should also address the adverse social conditions experienced by this population. [Author's abstract]
Highlights:
Five percent of French adults co-use tobacco and cannabis.
Most French adults who use cannabis use also tobacco.
Tobacco and cannabis co-use is associated with a lower socioeconomic status.
Affiliation :
Aix-Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l’Information Médicale, ISSPAM, Marseille, France
Santé Publique France, Saint-Maurice, France
Centre de Recherche en Épidémiologie et Santé des Populations (CESP), Inserm U1018, Université Paris-Saclay, Université Paris-Sud, Université Versailles Saint-Quentin (UVSQ), Villejuif, France
Santé Publique France, Saint-Maurice, France
Centre de Recherche en Épidémiologie et Santé des Populations (CESP), Inserm U1018, Université Paris-Saclay, Université Paris-Sud, Université Versailles Saint-Quentin (UVSQ), Villejuif, France